US Physical Therapy Inc
$
126.58
0.78 (0.62%)
| Volume: | 4,762 | Avg Vol (1m): | 91,727 |
| Market Cap $: | 1.60 Bil | Enterprise Value $: | 1.61 Bil |
| P/E (TTM): | 87.53 | P/B: | 7.20 |
| Earnings Power Value | 34.16 |
| Net Current Asset Value | -17.48 |
| Tangible Book | -9.58 |
| Projected FCF | 59.95 |
| Median P/S Value | 53.14 |
| Graham Number | 0 |
| Peter Lynch Value | 10.93 |
| DCF (FCF Based) | 61.68 |
| DCF (Earnings Based) | 15.3 |
1Y (-%)
Manual of Stocks™ Web
Financial Strength : 7.2/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Cash-to-Debt | 0.66 |
Cash-To-Debt range over the past 10 years
Min: 0.17, Med: 0.68, Max: 10000
Current: 0.66
| |
| Equity-to-Asset | 0.42 |
Equity-to-Asset range over the past 10 years
Min: 0.27, Med: 0.65, Max: 0.97
Current: 0.42
| |
| Debt-to-Equity | 0.14 |
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.23, Max: 2.18
Current: 0.14
| |
| Debt-to-EBITDA | 0.41 |
Debt-to-EBITDA range over the past 10 years
Min: 0.04, Med: 0.63, Max: 0.94
Current: 0.41
| |
| Interest Coverage | 33.94 |
Interest Coverage range over the past 10 years
Min: 2.6, Med: 46.45, Max: 140.64
Current: 33.94
| |
| Piotroski F-Score | 7 |
0
1
2
3
4
5
6
7
8
9
| |
| Altman Z-Score | 4.95 |
DISTRESS
GREY
SAFE
| |
| Beneish M-Score | -2.72 |
Not Manipulator
Manipulator
| |
| WACC vs ROIC % |
ROIC 21.49%
WACC 9.65%
| ||
Profitability & Growth : 8/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history | |
|---|---|---|---|
| Operating Margin % | 13.57 |
Operating Margin range over the past 10 years
Min: 13.22, Med: 14.16, Max: 15.71
Current: 13.57
| |
| Net Margin % | 7.84 |
Net Margin range over the past 10 years
Min: 4.82, Med: 6.25, Max: 9.06
Current: 7.84
| |
| ROE % | 8.55 |
ROE range over the past 10 years
Min: 7.89, Med: 13.46, Max: 19.88
Current: 8.55
| |
| ROA % | 7.94 |
ROA range over the past 10 years
Min: 5.78, Med: 8.13, Max: 13.79
Current: 7.94
| |
| ROC (Joel Greenblatt) % | 232.73 |
ROC (Joel Greenblatt) range over the past 10 years
Min: 96.79, Med: 124.13, Max: 232.73
Current: 232.73
| |
| 3-Year Total Revenue Growth Rate | 11.10 |
3-Year Revenue Growth Rate range over the past 10 years
Min: 7.1, Med: 12.7, Max: 181.8
Current: 10.3
| |
| 3-Year Total EBITDA Growth Rate | 9.20 |
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 8.2, Max: 30.9
Current: 8.4
| |
| 3-Year EPS w/o NRI Growth Rate | -7.60 |
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 7.6, Max: 127.6
Current: -7.6
|
» USPH's 30-Y Financials
Financials (Next Earnings Date: 2019-08-08)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NYSE:USPH
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Health Care Providers » Health Care Providers   NAICS : 621498   SIC : 8093 |
| Compare | TSE:7716 BKK:SVH-F JSE:NTC BOM:532843 SGX:BSL SZSE:000950 OTCPK:BLSTF BKK:BCH OHEL:TTALO ASX:HLS BKK:RAM-F SGX:A50 ISX:MIKA XTER:RHK KUW:MIDAN XSWX:AEVS NYSE:THC NAS:ADUS SAU:4004 NYSE:SEM |
| Traded in other countries | UPH.Germany |
| Address | 1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042 |
| US Physical Therapy Inc operates outpatient physical therapy and occupational therapy clinics throughout the United States. Its clinics provide treatment for orthopedic disorders, sports-related injuries, and work-related injuries. The company also administers care designed to prevent injuries from occurring. At the start of 2002, the company operated 170 clinics in more than 30 states. | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| PE Ratio (TTM) | 87.53 |
PE Ratio range over the past 10 years
Min: 8.91, Med: 25.34, Max: 89.99
Current: 87.53
| |
| Forward PE Ratio | 44.05 | N/A | |
| PE Ratio without NRI | 87.53 |
PE without NRI range over the past 10 years
Min: 8.91, Med: 22.82, Max: 89.99
Current: 87.53
| |
| Price-to-Owner-Earnings | 39.61 |
Price-to-Owner-Earnings range over the past 10 years
Min: 5.5, Med: 20.49, Max: 40.73
Current: 39.61
| |
| PB Ratio | 7.20 |
PB Ratio range over the past 10 years
Min: 1.12, Med: 3.07, Max: 7.69
Current: 7.2
| |
| PS Ratio | 3.46 |
PS Ratio range over the past 10 years
Min: 0.49, Med: 1.46, Max: 3.64
Current: 3.46
| |
| Price-to-Free-Cash-Flow | 25.33 |
Price-to-Free-Cash-Flow range over the past 10 years
Min: 3.33, Med: 10.48, Max: 27.32
Current: 25.33
| |
| Price-to-Operating-Cash-Flow | 22.36 |
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 2.83, Med: 9.36, Max: 24.32
Current: 22.36
| |
| EV-to-EBIT | 24.91 |
EV-to-EBIT range over the past 10 years
Min: 3.9, Med: 11.2, Max: 28.5
Current: 24.91
| |
| EV-to-EBITDA | 21.69 |
EV-to-EBITDA range over the past 10 years
Min: 3.1, Med: 9.9, Max: 24.3
Current: 21.69
| |
| EV-to-Revenue | 3.50 |
EV-to-Revenue range over the past 10 years
Min: 0.5, Med: 1.7, Max: 3.7
Current: 3.5
| |
| PEG Ratio | 10.70 |
PEG Ratio range over the past 10 years
Min: 0.83, Med: 3.14, Max: 11.48
Current: 10.7
| |
| Shiller PE Ratio | 77.21 |
Shiller PE Ratio range over the past 10 years
Min: 12.56, Med: 29.92, Max: 81.33
Current: 77.21
| |
| Current Ratio | 1.18 |
Current Ratio range over the past 10 years
Min: 1.18, Med: 4.4, Max: 42
Current: 1.18
| |
| Quick Ratio | 1.18 |
Quick Ratio range over the past 10 years
Min: 1.18, Med: 4.4, Max: 42
Current: 1.18
| |
| Days Sales Outstanding | 38.29 |
Days Sales Outstanding range over the past 10 years
Min: 35.99, Med: 41.85, Max: 47.21
Current: 38.29
| |
| Days Payable | 1.94 |
Days Payable range over the past 10 years
Min: 1.94, Med: 2.88, Max: 3.76
Current: 1.94
|
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| Dividend Yield % | 0.79 |
Trailing Dividend Yield range over the past 10 years
Min: 0.31, Med: 1.17, Max: 1.74
Current: 0.79
| |
| Dividend Payout Ratio | 0.67 |
Dividend Payout Ratio range over the past 10 years
Min: 0.2, Med: 0.33, Max: 0.7
Current: 0.67
| |
| 3-Year Dividend Growth Rate (Per Share) | 15.30 |
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 19.3
Current: 15.3
| |
| Forward Dividend Yield % | 0.95 | N/A | |
| Yield-on-Cost (5-Year) % | 1.84 |
Yield-on-Cost (5y) range over the past 10 years
Min: 0.71, Med: 2.69, Max: 4
Current: 1.84
| |
| 3-Year Share Buyback Rate | -0.70 |
3-Year Share Buyback Rate range over the past 10 years
Min: -9.8, Med: -0.9, Max: 7.7
Current: -0.7
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Price-to-Projected-FCF | 2.09 |
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.39, Med: 1.02, Max: 9.21
Current: 2.09
| |
| Price-to-DCF (Earnings Based) | 8.18 |
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 0.4, Med: 1.05, Max: 7.3
Current: 8.18
| |
| Price-to-Median-PS-Value | 2.36 |
Price-to-Median-PS-Value range over the past 10 years
Min: 0.42, Med: 1, Max: 14.08
Current: 2.36
| |
| Price-to-Peter-Lynch-Fair-Value | 11.45 |
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 0.47, Med: 1.71, Max: 11.77
Current: 11.45
| |
| Earnings Yield (Joel Greenblatt) % | 4.02 |
Earnings Yield (Greenblatt) range over the past 10 years
Min: 3.5, Med: 8.9, Max: 25.9
Current: 4.02
| |
| Forward Rate of Return (Yacktman) % | 10.51 |
Forward Rate of Return range over the past 10 years
Min: 10.5, Med: 15.2, Max: 26.9
Current: 10.51
|
More Statistics
| Revenue (TTM) (Mil) $ | 461.8 |
| EPS (TTM) $ | 1.43 |
| Beta | 1.3 |
| Volatility % | 34.67 |
| 52-Week Range $ | 98.69 - 129.65 |
| Shares Outstanding (Mil) | 12.76 |
Analyst Estimate
Piotroski F-Score Details
| Piotroski F-Score | 7 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA yoy | Y |
| CFROA > ROA | Y |
| Lower Leverage yoy | Y |
| Higher Current Ratio yoy | N |
| Less Shares Outstanding yoy | N |
| Higher Gross Margin yoy | Y |
| Higher Asset Turnover yoy | Y |